B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

UGT1A4

MOLECULAR TARGET

UDP glucuronosyltransferase family 1 member A4

UniProt: P22310NCBI Gene: 546571 compounds

UGT1A4 (UDP glucuronosyltransferase family 1 member A4) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting UGT1A4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Anastrozole0.691

About UGT1A4 as a Drug Target

UGT1A4 (UDP glucuronosyltransferase family 1 member A4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented UGT1A4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

UGT1A4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.